Kenneth Katschke

Title: Kenneth Katschke: Innovator in Macrophage Receptor Research

Introduction

Kenneth Katschke is a notable inventor based in Millbrae, CA (US). He has made significant contributions to the field of biochemistry, particularly in the study of macrophage-specific receptors. With a total of 2 patents, Katschke's work has implications for understanding immune responses and developing therapeutic agents.

Latest Patents

Katschke's latest patents focus on the crystal structure of the macrophage-specific receptor, CRIg, and its complex with the C3b and C3c subunits of complement C3. The inventions detail the determination of these crystal structures, which are crucial for screening and identifying molecules that are structurally or functionally related to CRIg. This includes potential CRIg agonists and antagonists, which could lead to advancements in medical treatments.

Career Highlights

Kenneth Katschke is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to explore the intricate mechanisms of immune receptors and their potential therapeutic applications.

Collaborations

Throughout his career, Katschke has collaborated with esteemed colleagues such as Philip E. Hass and Jianping Yin. These collaborations have enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Kenneth Katschke's contributions to the understanding of macrophage receptors and their complexes are invaluable. His innovative patents and collaborations highlight his role as a key figure in biochemistry and immunology.